Navigation Links
Sundia Receives 2011 Zero2IPO Venture 50 Award
Date:11/21/2011

SHANGHAI, Nov. 21, 2011 /PRNewswire-Asia/ -- Sundia MediTech Company Inc., a leading pharmaceutical Contract Research Organization (CRO) in China, announced that the company was named one of the 50 best companies for investment in China in 2011 by Zero2IPO. The news was announced at an October ceremony in Shanghai. This is the third time for Sundia to get this prestigious award after it was previously named in 2007 and 2008.

Zero2IPO-Venture 50 was launched by Zero2IPO Group in 2006. Until now it has become the highest level of enterprise appraisal by venture capitalists in China, and reflects the enterprise with the most potential. The 50 enterprises with the most investment value were selected from a pool of thousands of nominated companies in leading industries by evaluating nominees' business on management team, ownership structure, business model, competitiveness, industry and market, financial situation and forecast, management risks and strategy.

Sundia was founded in 2004 in Shanghai by a group of biotech and pharmaceutical industry veterans from North America. The company has provided integrated R&D outsourcing services to biotech and pharmaceutical clients worldwide. Over the past 7 years, Sundia has successfully established collaborations with over 100 clients in North America, Europe, Japan, Korea and China. Now, Sundia has become a top CRO company in China with 700 employees with operations in Shanghai and Shijiazhuang, the capital city of Hebei Province in Northern China.

Dr. Xiaochuan Wang, Chairman of Sundia attended the ceremony and made a reception speech. "We really appreciate the venture investor for voting Sundia into Venture 50 again. It is recognition of the effort of all of our team members," she acknowledged.


'/>"/>
SOURCE Sundia MediTech Company Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Amsterdam Molecular Therapeutics Receives Orphan Designation in the European Union for Hemophilia B Gene Therapy
2. Vascular Designs, Inc. Receives CE Mark Approval for Its IsoFlow™ Infusion Catheter to Target Cancerous Tumors
3. Qualitest Pharmaceuticals Receives FDA Approval for Acetaminophen and Codeine Phosphate Oral Solution USP, 120mg/12mg per 5mL
4. First Patient Receives FDA-Approved Telescope Implant for End-Stage Macular Degeneration
5. Ethicon Endo-Surgery Receives 510(k) Clearance for New ENSEAL® G2 Curved and Straight Tissue Sealers Line -- Broadest Range of Advanced Bipolar Tissue Sealers Available for Open and Minimally Invasive Surgery
6. Nephros Receives Initial FDA Response to 510(k) Application for Hemodiafiltration System
7. IDEV Technologies Receives FDA Clearance for Its SUPERA VERITAS® 6 French Stent Delivery System
8. Augurix Diagnostics Receives the 2011 Debiopharm /Valais Award for its Point-of-care Diagnostic Test for the Early Detection of Celiac Disease
9. The Childrens Hospital of Philadelphia Receives Grand Challenges Explorations Funding
10. Femasys Receives FDA 510(k) Clearance for First Low Pressure HSG Device
11. PTC Therapeutics Receives Grand Challenges Explorations Funding
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... -- Research and Markets has announced the addition ... report to their offering. ... The World Market for Companion Diagnostics covers the world ... in the report includes the following: , ... by Region (N. America, EU, ROW), 2015-2020 , World ...
(Date:6/23/2016)... , June 23, 2016  MedSource announced today ... its e-clinical software solution of choice.  This latest ... possible value to their clients by offering a ... preferred relationship establishes nowEDC as the EDC platform ... MedSource,s full-service clients.  "nowEDC has long been a ...
(Date:6/23/2016)... , June 23, 2016 Roche (SIX: RO, ... clearance for its Elecsys BRAHMS PCT (procalcitonin) assay as ... or septic shock. With this clearance, Roche is the ... fully integrated solution for sepsis risk assessment and management. ... bacterial infection and PCT levels in blood can aid ...
Breaking Medicine Technology:
(Date:6/24/2016)... ... ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business for ... $12 an hour by 2020 and then adjusting it yearly to increase at the same ... wage, assure the wage floor does not erode again, and make future increases more predictable. ...
(Date:6/24/2016)... ... June 24, 2016 , ... EB Medicine presented its first-ever ... Medicine conference in Ponte Vedra Beach, FL. The awards honor the outstanding work ... Practice and Pediatric Emergency Medicine Practice. , “With this award, we recognize ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... client, The Grove Investment Group (TGIG), has initiated cultivation and processing operations at ... Las Vegas and Pahrump, Nevada. , Puradigm is the manufacturer of a complete ...
(Date:6/24/2016)... ... June 24, 2016 , ... National recruitment firm ... sciences executive with extensive sequencing and genomics experience, as Vice President of North American ... Hill will be responsible for leading the sales team in the commercialization of the ...
(Date:6/24/2016)... ... June 24, 2016 , ... Today, MTI-GlobalStem, ... (iPS) cells and other difficult to transfect cells, announces its launch of the ... G9™ Gene Editing System is a complete system for culturing and transfecting ...
Breaking Medicine News(10 mins):